Last updated 4 days ago
Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2
700 patients around the world
Available in Peru, Argentina
Seagen Inc.
5Research sites
700Patients around the world
This study is for people with
Urothelial cancer
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
Centro de Investigaciones Clínicas - Clínica Viedma - Río Negro
Recruiting
Centro Oncológico Korben
Recruiting
Oncología Salta
Recruiting
Investigaciones Clínicas Moleculares - ICM
Recruiting
Hospital Maria Auxiliadora - Lima
Recruiting
SponsorSeagen Inc.
Conditions
Urothelial cancer
Requirements
From 18 YearsAll Gender
Unique study IDclinicaltrials.gov
NCT05911295
